Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Treatment of advanced non-small cell lung cancer De Petris L; Crino L; Scagliotti GV; Gridelli C; Galetta D; Metro G; Novello S; Maione P; Colucci G; de Marinis FAnn Oncol 2006[Mar]; 17 Suppl 2 (ä): ii36-41In the last decade the treatment of advanced-metastatic non-small cell lung cancer has substantially improved. If in the early 90s there was still concern about the real efficacy of chemotherapy over best suppotive care alone in the advanced setting, constant developments in clinical research have demonstrated the survival advantage of active anti-cancer drugs not only in the first-line setting, but, lately, even in patients with recurrent disease after failure of two previous chemotherapy lines. With the premises of high throughput technologies, translational research is aiming to characterize patients and tumors on a molecular basis. With pharmacogenomics it would then be possible to accurately predict patient outcome and tailor the treatment strategy according to the geno-phenotype of single patients.|*Antineoplastic Combined Chemotherapy Protocols[MESH]|Carcinoma, Non-Small-Cell Lung/*drug therapy/pathology[MESH]|Humans[MESH]|Lung Neoplasms/*drug therapy/pathology[MESH]|Medical Oncology[MESH]|Neoplasm Metastasis/drug therapy[MESH]|Neoplasm Staging[MESH]|Pharmacogenetics[MESH]|Platinum Compounds/administration & dosage[MESH]|Prognosis[MESH] |